Cannabis Rescheduling

DEA Public Comment Period And A Cannabis-Related Crypto Bill? You Heard It First At Benzinga Conference
Canopy Is 'Cautiously Optimistic' On Cannabis Rescheduling Following Major Step Toward Entry Into US THC Market
Biden Champions Cannabis Reform And Pardon As Election Pressure Mounts, Marijuana Takes Center Stage
Canopy Is 'Cautiously Optimistic' On Cannabis Rescheduling Following Major Step Toward Entry Into US THC Market
Biden Champions Cannabis Reform And Pardon As Election Pressure Mounts, Marijuana Takes Center Stage
Governor Polis Calls For Federal Cannabis Rescheduling, Launches New State Business Program
Future-Proofing The Cannabis Industry: CEO Forecasts M&A Trends And Moves On Emerging Markets

Cannabis Rescheduling Recent News

VP Kamala Harris Urges DEA To Reschedule Cannabis 'As Quickly As Possible,' Calls Prohibition 'Absurd' & 'Unfair'
In a significant move to address long-standing issues within the U.S.
Cannabis Stocks Jump On News That DEA May Soon Undertake Marijuana Reform
Doug Kass, world-renowned hedge fund manager, posted on X, formerly Twitter, Friday that the "DEA will approve a rescheduling of cannabis to Schedule III." 
DEA Vs. White House: Agency Pushes Back On Medical Benefits Of Cannabis, Weed Stocks Wobble
In addition to reportedly doubting the scientific evidence presented by HHS, the DEA also expressed concern about the increasing potency of THC, the psychoactive compound in cannabis. Marijuana advocates and stakeholders question the motivations behind these anonymous claims, as the DEA itself has not publicly opposed the recommendation. The agency is conducting its own review, with Administrator Anne Milgram promising to consider all available research.
Cannabis Industry Veteran On Market Trends, DEA Rescheduling, THC Types, Psychedelics And More
In a recent podcast, David Traylor shares insights on the evolving cannabis and psychedelics industries, advocating for scientific research and financial fortitude amidst regulatory challenges.
[Video] Cannabis Industry's 2024 Outlook: Expert Analysis From Highway 33 Capital Advisory
Cannabis Operators Are Not Risk-Takers Living On The Edge, Most Are Compliant, Says Marijuana Lawyer
Biden Admin Official Denies Cannabis Shift Rumors, Gen-Zers Say They Can Drive Stoned, FLA Caps Weed Strength & More Updates
DEA Poised To Reschedule Cannabis This Week? Something's Brewing In The White House, Says This Insider
The Drug Enforcement Administration (DEA) is apparently on the verge of rescheduling cannabis, potentially within days or weeks. The move would mark the most significant federal action toward marijuana legalization since its prohibition nearly a century ago.
Biden's Weed Promise, The Federal Govt. & 2024 Elections: Analyzing Stock Values, Taxes & Timing
Amidst President Joe Biden’s campaign promises, rescheduling marijuana from Schedule I to Schedule III is seen as the most impactful on the stock market, possibly positively fueling stock rallies.
Senator Gillibrand Urges Biden Administration To Deschedule Marijuana: 'It's A Medical Issue And It's A Public Safety Issue'
Gillibrand urges Biden admin to deschedule cannabis for social justice, economic, medical and public safety reasons. Rescheduling to Schedule III won't do enough.
US Cannabis Stocks Surge By 69%: Water Tower Research Report Breaks Down Top Performers
In a recent report from Water Tower Research, authored by analyst Jesse Redmond, the cannabis industry's current landscape paints an interesting, if optimistic, picture.
DOJ To Federal Court: Don't Disrupt DEA's Rescheduling Process, Drop Cannabis Industry Lawsuit — Legal Tug-Of-War Continues
The DOJ's emphasis on the ongoing DEA rescheduling process suggests a potential willingness to reconsider cannabis's classification.
2024 Oscars Of Marijuana Equity: Analyst Nominations Spotlight Key State Performers
In his latest cannabis sector equity report, senior analyst Pablo Zuanic of Zuanic & Associates offers a detailed examination of the cannabis sector's landscape in the fourth quarter of 2023.
Marijuana Reclassification And DEA: Congressional Report Outlines Rescheduling Limits
The congressional report is a reminder that the road to legal weed is paved with unexpected detours and Congress and the DEA hold the keys.
Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about potential regulatory changes that could benefit the cannabis industry after the US government released 252 pages of documents confirming the HHS's recommendation that the DEA reschedule cannabis as Schedule III under the Controlled Substances Act. The documents state that cannabis has a currently accepted medical use in treatment and potential for abuse less than drugs in Schedules I and II. In August, the Assistant Secretary for Health wrote a letter to the DEA calling for marijuana to be reclassified. The Secretary of HHS has confirmed that his department shared a comprehensive scientific review with the DEA in response to President Joe Biden's scheduling directive.
EXCLUSIVE: Key Legal And Tax Ramifications Of Federal Cannabis Rescheduling, Insights From Dykema Gossett PLLC
Amidst potential shifts in U.S. cannabis regulation, Lance Boldrey, leader of Cannabis Law Practice at Dykema Gossett PLLC, analyzes the potential impact of reclassifying cannabis to Schedule III under the Controlled Substance Act.
Marijuana Rescheduling, Stock Market Reactions: Analyst Insights On Who Wins & Possible Trump Election
The anticipated shift of cannabis to Schedule III marks a pivotal moment for U.S. cannabis companies.
National Cannabis Roundtable Applauds 'Historic' HHS Recommendation To Reschedule Cannabis
Following the release of documents from the U.S.
Feds Finally Release Documents Confirming Recommendation To Reschedule Cannabis Based On 'Accepted Medical Use'
The U.S.
12 State Attorneys General To DEA: Reschedule Marijuana To 'Defend Public Safety,' Cannabis Stocks Jump
In a major development in the ongoing debate over marijuana policy, 12 Democratic state attorneys general have formally requested the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III of the Controlled Substances Act.
Federal Agency To Release All Redacted Documents Related To Cannabis Rescheduling Memo, Amid Litigation
Congressman Presses DEA On Marijuana Rescheduling Review: 'Move As Swiftly As Possible'
U.S. Rep Steve Cohen (D-TN) has fired a shot across the bow of the Drug Enforcement Administration (DEA), demanding swift action on the ongoing review of marijuana's federal classification.
DEA To Congress: We Hold 'Final Authority' On Cannabis Rescheduling, Overruling Biden's Health Authorities
The Drug Enforcement Administration (DEA) told House lawmakers that the agency is “now conducting its review” of marijuana as a Schedule 1 drug, according to a letter obtained by Punchbowl News.